Senior Director, In Vivo Pharmacology at Abata Therapeutics

San Carlos, California, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • PhD in Molecular & Cell Biology, Genetics, Biochemistry, Immunology, Physiology or related areas
  • Minimum 15 years of experience designing, executing, and overseeing in vivo pharmacology studies to support projects in the pharmaceutical or biotech industry, with emphasis on in vivo models of immunology and inflammation in the gut, skin, respiratory organs, and autoimmune diseases
  • Minimum 10 years of experience managing teams and representing Pharmacology on cross-functional teams
  • Experience in generating and managing pre-IND reports (strongly preferred)
  • Prior experience with biologics drug discovery and development (preferred)
  • Previous experience working in fast-paced start-up environments (preferred)
  • Strong technical expertise in study design methodologies and a wide range of in vivo autoimmune and inflammatory disease models
  • Strategic thinker with ability to analyze possibilities, evaluate benefits/risks, and develop mitigation strategies and solutions
  • Strong leadership and program management skills, including experience building, leading, and developing strong and collaborative scientific teams
  • Strong communication skills, with ability to effectively collaborate with cross-functional teams and external partners
  • Demonstrated ability to stay updated with latest advancements and trends in in vivo research
  • Proactive and able to work effectively on multiple projects in a fast-paced, dynamic environment
  • Strong written and verbal communication skills

Responsibilities

  • Provide leadership in preclinical pharmacological program development from target validation to successful regulatory filings for mono- and multispecific biologics
  • Manage all in-vivo pharmacology studies, including design, implementation, conduct, and reporting
  • Facilitate the conceptualization and development of innovative research strategies and plans for preclinical studies aligned with the company's therapeutic portfolio and goals
  • Identify, assess, and oversee various contract research organizations (CROs) to complement internal capabilities and generate critical pharmacokinetic, pharmacodynamic, and efficacy data
  • Foster effective collaboration and communication with internal teams, external partners, and key stakeholders to ensure alignment of research objectives and facilitate knowledge sharing
  • Perform independent research within the field of study to provide leadership to advance optimization of in vivo research methodologies, technologies, and industry trends
  • Develop and present Pharmacology strategy, plans, and data at project team meetings and to management to support project objectives
  • Support the filing of regulatory documents, including preparation of final study reports and IND (or related) documents
  • Contribute to a team culture that promotes collaboration, open communication, career development, excellence, ownership, curiosity, and inclusion
  • Lead a small but motivated in vivo team
  • Collaborate with cross-functional partners to manage resource allocations to enable portfolio progression

Skills

Key technologies and capabilities for this role

In Vivo PharmacologyPreclinical StudiesPharmacokineticsPharmacodynamicsEfficacy StudiesCRO ManagementTarget ValidationTranslational BiologyRegulatory FilingsFDA INDBiologicsMultispecific AntibodiesImmunologyInflammation

Questions & Answers

Common questions about this position

What qualifications are required for the Senior Director, In Vivo Pharmacology role?

Candidates need a PhD in Molecular & Cell Biology, Genetics, Biochemistry, Immunology, Physiology or related areas, with minimum 15 years of experience designing, executing, and overseeing in vivo pharmacology studies focused on immunology and inflammation, and at least 10 years managing teams.

Is this position remote or onsite?

The role is onsite preferred.

What is the salary or compensation for this position?

This information is not specified in the job description.

What team will the Senior Director lead?

The position will lead a small but motivated in vivo team.

What does the company value in its team culture?

The company promotes a team culture that fosters collaboration, open communication, career development, excellence, ownership, curiosity, and inclusion.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI